INTRODUCTION: The aim of this study was to evaluate the influence of flurodeoxyglucose positron emission tomography computed tomography (FDG PET-CT), as an adjunct to conventional CT staging, in the detection of extrahepatic disease in patients with potentially resectable colorectal liver metastasis. METHODS: Overall, 133 consecutive patients with colorectal liver metastases staged with CT and PET-CT referred to the East Lancashire regional hepatobiliary multidisciplinary team over a two-year period were included in this study. Abnormal findings on PET-CT were correlated with follow-up imaging and/or histology. All imaging was reviewed by specialist hepatobiliary radiologists for the presence/absence of extrahepatic disease. The influence of the PET-CT findings was categorised for each patient in relation to operability and other significant findings. RESULTS: PET-CT had a major impact on staging of extra hepatic disease in 20% of patients, in comparison with the initial CT. Six per cent of patients were upstaged from operable CT findings to inoperable findings on PET-CT because of the discovery of inoperable occult extrahepatic disease. Five per cent had operable local regional nodal disease detected on PET-CT. A further 3% had premalignant colorectal lesions detected on PET-CT. Six per cent of patients were downstaged from indeterminate or suspected inoperable CT findings to operable findings on PET-CT. CONCLUSIONS: The use of PET-CT in this setting may prevent futile operations, guide the resection of local regional nodal disease and downstage a number of patients thought to have extrahepatic disease on conventional imaging. This study has shown similar results to other recent studies and supports the use of PET-CT as a necessary staging modality in patients with potentially resectable colorectal liver metastases.
INTRODUCTION: The aim of this study was to evaluate the influence of flurodeoxyglucose positron emission tomography computed tomography (FDG PET-CT), as an adjunct to conventional CT staging, in the detection of extrahepatic disease in patients with potentially resectable colorectal liver metastasis. METHODS: Overall, 133 consecutive patients with colorectal liver metastases staged with CT and PET-CT referred to the East Lancashire regional hepatobiliary multidisciplinary team over a two-year period were included in this study. Abnormal findings on PET-CT were correlated with follow-up imaging and/or histology. All imaging was reviewed by specialist hepatobiliary radiologists for the presence/absence of extrahepatic disease. The influence of the PET-CT findings was categorised for each patient in relation to operability and other significant findings. RESULTS: PET-CT had a major impact on staging of extra hepatic disease in 20% of patients, in comparison with the initial CT. Six per cent of patients were upstaged from operable CT findings to inoperable findings on PET-CT because of the discovery of inoperable occult extrahepatic disease. Five per cent had operable local regional nodal disease detected on PET-CT. A further 3% had premalignant colorectal lesions detected on PET-CT. Six per cent of patients were downstaged from indeterminate or suspected inoperable CT findings to operable findings on PET-CT. CONCLUSIONS: The use of PET-CT in this setting may prevent futile operations, guide the resection of local regional nodal disease and downstage a number of patients thought to have extrahepatic disease on conventional imaging. This study has shown similar results to other recent studies and supports the use of PET-CT as a necessary staging modality in patients with potentially resectable colorectal liver metastases.
Authors: E D Rappeport; A Loft; A K Berthelsen; P von der Recke; P Noergaard Larsen; A Mellon Mogensen; A Wettergren; A Rasmussen; J Hillingsoe; P Kirkegaard; C Thomsen Journal: Acta Radiol Date: 2007-05 Impact factor: 1.990
Authors: Pier Paolo Mainenti; Marcello Mancini; Ciro Mainolfi; Luigi Camera; Simone Maurea; Antonietta Manchia; Michela Tanga; Francesco Persico; Pietro Addeo; Dario D'Antonio; Antonio Speranza; Luigi Bucci; Giovanni Persico; Leonardo Pace; Marco Salvatore Journal: Abdom Imaging Date: 2009-06-27
Authors: Shandra Bipat; Maarten S van Leeuwen; Emile F I Comans; Milan E J Pijl; Patrick M M Bossuyt; Aeilko H Zwinderman; Jaap Stoker Journal: Radiology Date: 2005-08-11 Impact factor: 11.105
Authors: G Kong; C Jackson; D M Koh; V Lewington; B Sharma; G Brown; D Cunningham; G J R Cook Journal: Eur J Nucl Med Mol Imaging Date: 2008-03-18 Impact factor: 9.236
Authors: K S Hughes; R Simon; S Songhorabodi; M A Adson; D M Ilstrup; J G Fortner; B J Maclean; J H Foster; J M Daly; D Fitzherbert Journal: Surgery Date: 1986-08 Impact factor: 3.982
Authors: Ricky Harminder Bhogal; James Hodson; Simon Roderick Bramhall; John Isaac; Ravi Marudanayagam; Darius Feroze Mirza; Paolo Muiesan; Robert Peter Sutcliffe Journal: World J Surg Oncol Date: 2015-04-01 Impact factor: 2.754
Authors: Tim Akhurst; Mithat Gönen; Raymond E Baser; Lawrence H Schwartz; Scott Tuorto; Lynn A Brody; Anne Covey; Karen T Brown; Steven M Larson; Yuman Fong Journal: Hepatobiliary Surg Nutr Date: 2022-08 Impact factor: 8.265
Authors: A K E Elfrink; M Pool; L R van der Werf; E Marra; M C Burgmans; M R Meijerink; M den Dulk; P B van den Boezem; W W Te Riele; G A Patijn; M W J M Wouters; W K G Leclercq; M S L Liem; P D Gobardhan; C I Buis; K F D Kuhlmann; C Verhoef; M G Besselink; D J Grünhagen; J M Klaase; N F M Kok Journal: BJS Open Date: 2020-05-06